Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Targher

Showing results (21-30 of 637) with videos related to

Pageof 64
Sort By:
The New England Journal of Medicine|June 1, 2012
Pasireotide in Cushing's diseaseGiovanni Targher
The New England Journal of Medicine|March 10, 2007
Pioglitazone in nonalcoholic steatohepatitisGiovanni Targher
Metabolites|October 14, 2020
What's Past Is Prologue: History of Nonalcoholic Fatty Liver DiseaseGiovanni Targher
Alimentary Pharmacology & Therapeutics|December 12, 2023
Editorial: Resmetirom - a promising treatment option for NASH and liver fibrosisGiovanni Targher
Atherosclerosis|September 15, 2006
Non-alcoholic fatty liver disease and increased risk of cardiovascular diseaseGiovanni Targher, Guido Arcaro
International Journal of Epidemiology|December 14, 2011
Commentary: Liver enzymes and the risk of adverse cardiovascular outcomes--the lower, the better?Giulio Marchesini, Giovanni Targher
JAMA|January 8, 2020
High-Dose Vitamin D Supplementation and Bone HealthGiuseppe Lippi, Giovanni Targher
Nature Reviews. Gastroenterology & Hepatology|February 26, 2025
Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicineNorbert Stefan, Giovanni Targher
Journal of Hepatology|December 19, 2024
Not all fat is alike in MASLDAmedeo Lonardo, Giovanni Targher
International Journal of Molecular Sciences|September 13, 2017
NAFLD: Is There Anything New under the Sun?Amedeo Lonardo, Giovanni Targher
Pageof 64

Showing results (21-30 of 637) with videos related to

Sort By:
Pageof 64
The New England Journal of Medicine|June 1, 2012
Pasireotide in Cushing's diseaseGiovanni Targher
The New England Journal of Medicine|March 10, 2007
Pioglitazone in nonalcoholic steatohepatitisGiovanni Targher
Metabolites|October 14, 2020
What's Past Is Prologue: History of Nonalcoholic Fatty Liver DiseaseGiovanni Targher
Alimentary Pharmacology & Therapeutics|December 12, 2023
Editorial: Resmetirom - a promising treatment option for NASH and liver fibrosisGiovanni Targher
Atherosclerosis|September 15, 2006
Non-alcoholic fatty liver disease and increased risk of cardiovascular diseaseGiovanni Targher, Guido Arcaro
International Journal of Epidemiology|December 14, 2011
Commentary: Liver enzymes and the risk of adverse cardiovascular outcomes--the lower, the better?Giulio Marchesini, Giovanni Targher
JAMA|January 8, 2020
High-Dose Vitamin D Supplementation and Bone HealthGiuseppe Lippi, Giovanni Targher
Nature Reviews. Gastroenterology & Hepatology|February 26, 2025
Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicineNorbert Stefan, Giovanni Targher
Journal of Hepatology|December 19, 2024
Not all fat is alike in MASLDAmedeo Lonardo, Giovanni Targher
International Journal of Molecular Sciences|September 13, 2017
NAFLD: Is There Anything New under the Sun?Amedeo Lonardo, Giovanni Targher
Pageof 64